Global Gastrointestinal Stromal Tumors Therapeutics Market Research Report 2025(Status and Outlook)
Report Overview
The global Gastrointestinal Stromal Tumors Therapeutics market size was estimated at USD 1433.58 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gastrointestinal Stromal Tumors Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gastrointestinal Stromal Tumors Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gastrointestinal Stromal Tumors Therapeutics market
Global Gastrointestinal Stromal Tumors Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ascentage Pharma Group International
Bayer AG
Blueprint Medicines Corp
Bristol Myers Squibb Co.
Deciphera Pharmaceuticals Inc
Immunicum AB
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Xencor Inc.
Market Segmentation (by Type)
Oral
Non-oral
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumors Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal Stromal Tumors Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Gastrointestinal Stromal Tumors Therapeutics market size was estimated at USD 1433.58 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gastrointestinal Stromal Tumors Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gastrointestinal Stromal Tumors Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gastrointestinal Stromal Tumors Therapeutics market
Global Gastrointestinal Stromal Tumors Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ascentage Pharma Group International
Bayer AG
Blueprint Medicines Corp
Bristol Myers Squibb Co.
Deciphera Pharmaceuticals Inc
Immunicum AB
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Xencor Inc.
Market Segmentation (by Type)
Oral
Non-oral
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gastrointestinal Stromal Tumors Therapeutics Market
- Overview of the regional outlook of the Gastrointestinal Stromal Tumors Therapeutics Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumors Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal Stromal Tumors Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumors Therapeutics
1.2 Key Market Segments
1.2.1 Gastrointestinal Stromal Tumors Therapeutics Segment by Type
1.2.2 Gastrointestinal Stromal Tumors Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gastrointestinal Stromal Tumors Therapeutics Product Life Cycle
3.3 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastrointestinal Stromal Tumors Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastrointestinal Stromal Tumors Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gastrointestinal Stromal Tumors Therapeutics Market Competitive Situation and Trends
3.8.1 Gastrointestinal Stromal Tumors Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumors Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Stromal Tumors Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gastrointestinal Stromal Tumors Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gastrointestinal Stromal Tumors Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Gastrointestinal Stromal Tumors Therapeutics Price by Type (2020-2025)
7 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Sales by Application (2020-2025)
7.3 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2020-2025)
8 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SALES BY REGION
8.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region
8.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Region
8.2.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Region
8.2.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region
8.3 North America
8.3.1 North America Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.3.2 North America Gastrointestinal Stromal Tumors Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.4.2 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.5.2 Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.6.2 South America Gastrointestinal Stromal Tumors Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.7.2 Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Gastrointestinal Stromal Tumors Therapeutics by Region(2020-2025)
9.2 Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Gastrointestinal Stromal Tumors Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gastrointestinal Stromal Tumors Therapeutics Production
9.4.1 North America Gastrointestinal Stromal Tumors Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Gastrointestinal Stromal Tumors Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gastrointestinal Stromal Tumors Therapeutics Production
9.5.1 Europe Gastrointestinal Stromal Tumors Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Gastrointestinal Stromal Tumors Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gastrointestinal Stromal Tumors Therapeutics Production (2020-2025)
9.6.1 Japan Gastrointestinal Stromal Tumors Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Gastrointestinal Stromal Tumors Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gastrointestinal Stromal Tumors Therapeutics Production (2020-2025)
9.7.1 China Gastrointestinal Stromal Tumors Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Gastrointestinal Stromal Tumors Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ascentage Pharma Group International
10.1.1 Ascentage Pharma Group International Basic Information
10.1.2 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.1.3 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.1.4 Ascentage Pharma Group International Business Overview
10.1.5 Ascentage Pharma Group International SWOT Analysis
10.1.6 Ascentage Pharma Group International Recent Developments
10.2 Bayer AG
10.2.1 Bayer AG Basic Information
10.2.2 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.2.3 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.2.4 Bayer AG Business Overview
10.2.5 Bayer AG SWOT Analysis
10.2.6 Bayer AG Recent Developments
10.3 Blueprint Medicines Corp
10.3.1 Blueprint Medicines Corp Basic Information
10.3.2 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.3.3 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.3.4 Blueprint Medicines Corp Business Overview
10.3.5 Blueprint Medicines Corp SWOT Analysis
10.3.6 Blueprint Medicines Corp Recent Developments
10.4 Bristol Myers Squibb Co.
10.4.1 Bristol Myers Squibb Co. Basic Information
10.4.2 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.4.3 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.4.4 Bristol Myers Squibb Co. Business Overview
10.4.5 Bristol Myers Squibb Co. Recent Developments
10.5 Deciphera Pharmaceuticals Inc
10.5.1 Deciphera Pharmaceuticals Inc Basic Information
10.5.2 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.5.3 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.5.4 Deciphera Pharmaceuticals Inc Business Overview
10.5.5 Deciphera Pharmaceuticals Inc Recent Developments
10.6 Immunicum AB
10.6.1 Immunicum AB Basic Information
10.6.2 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.6.3 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.6.4 Immunicum AB Business Overview
10.6.5 Immunicum AB Recent Developments
10.7 Novartis AG
10.7.1 Novartis AG Basic Information
10.7.2 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.7.3 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.7.4 Novartis AG Business Overview
10.7.5 Novartis AG Recent Developments
10.8 Pfizer Inc.
10.8.1 Pfizer Inc. Basic Information
10.8.2 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.8.3 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.8.4 Pfizer Inc. Business Overview
10.8.5 Pfizer Inc. Recent Developments
10.9 Sun Pharmaceutical Industries Ltd
10.9.1 Sun Pharmaceutical Industries Ltd Basic Information
10.9.2 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.9.3 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.9.4 Sun Pharmaceutical Industries Ltd Business Overview
10.9.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.10 Xencor Inc.
10.10.1 Xencor Inc. Basic Information
10.10.2 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.10.3 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.10.4 Xencor Inc. Business Overview
10.10.5 Xencor Inc. Recent Developments
11 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast
11.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region
11.2.4 South America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gastrointestinal Stromal Tumors Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumors Therapeutics by Type (2026-2033)
12.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumors Therapeutics by Type (2026-2033)
12.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Application (2026-2033)
12.2.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumors Therapeutics
1.2 Key Market Segments
1.2.1 Gastrointestinal Stromal Tumors Therapeutics Segment by Type
1.2.2 Gastrointestinal Stromal Tumors Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gastrointestinal Stromal Tumors Therapeutics Product Life Cycle
3.3 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastrointestinal Stromal Tumors Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastrointestinal Stromal Tumors Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gastrointestinal Stromal Tumors Therapeutics Market Competitive Situation and Trends
3.8.1 Gastrointestinal Stromal Tumors Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumors Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Stromal Tumors Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gastrointestinal Stromal Tumors Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gastrointestinal Stromal Tumors Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Gastrointestinal Stromal Tumors Therapeutics Price by Type (2020-2025)
7 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Sales by Application (2020-2025)
7.3 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2020-2025)
8 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET SALES BY REGION
8.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region
8.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Region
8.2.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Region
8.2.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region
8.3 North America
8.3.1 North America Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.3.2 North America Gastrointestinal Stromal Tumors Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.4.2 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.5.2 Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gastrointestinal Stromal Tumors Therapeutics Sales by Country
8.6.2 South America Gastrointestinal Stromal Tumors Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales by Region
8.7.2 Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Gastrointestinal Stromal Tumors Therapeutics by Region(2020-2025)
9.2 Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Gastrointestinal Stromal Tumors Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gastrointestinal Stromal Tumors Therapeutics Production
9.4.1 North America Gastrointestinal Stromal Tumors Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Gastrointestinal Stromal Tumors Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gastrointestinal Stromal Tumors Therapeutics Production
9.5.1 Europe Gastrointestinal Stromal Tumors Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Gastrointestinal Stromal Tumors Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gastrointestinal Stromal Tumors Therapeutics Production (2020-2025)
9.6.1 Japan Gastrointestinal Stromal Tumors Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Gastrointestinal Stromal Tumors Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gastrointestinal Stromal Tumors Therapeutics Production (2020-2025)
9.7.1 China Gastrointestinal Stromal Tumors Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Gastrointestinal Stromal Tumors Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ascentage Pharma Group International
10.1.1 Ascentage Pharma Group International Basic Information
10.1.2 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.1.3 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.1.4 Ascentage Pharma Group International Business Overview
10.1.5 Ascentage Pharma Group International SWOT Analysis
10.1.6 Ascentage Pharma Group International Recent Developments
10.2 Bayer AG
10.2.1 Bayer AG Basic Information
10.2.2 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.2.3 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.2.4 Bayer AG Business Overview
10.2.5 Bayer AG SWOT Analysis
10.2.6 Bayer AG Recent Developments
10.3 Blueprint Medicines Corp
10.3.1 Blueprint Medicines Corp Basic Information
10.3.2 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.3.3 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.3.4 Blueprint Medicines Corp Business Overview
10.3.5 Blueprint Medicines Corp SWOT Analysis
10.3.6 Blueprint Medicines Corp Recent Developments
10.4 Bristol Myers Squibb Co.
10.4.1 Bristol Myers Squibb Co. Basic Information
10.4.2 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.4.3 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.4.4 Bristol Myers Squibb Co. Business Overview
10.4.5 Bristol Myers Squibb Co. Recent Developments
10.5 Deciphera Pharmaceuticals Inc
10.5.1 Deciphera Pharmaceuticals Inc Basic Information
10.5.2 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.5.3 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.5.4 Deciphera Pharmaceuticals Inc Business Overview
10.5.5 Deciphera Pharmaceuticals Inc Recent Developments
10.6 Immunicum AB
10.6.1 Immunicum AB Basic Information
10.6.2 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.6.3 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.6.4 Immunicum AB Business Overview
10.6.5 Immunicum AB Recent Developments
10.7 Novartis AG
10.7.1 Novartis AG Basic Information
10.7.2 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.7.3 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.7.4 Novartis AG Business Overview
10.7.5 Novartis AG Recent Developments
10.8 Pfizer Inc.
10.8.1 Pfizer Inc. Basic Information
10.8.2 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.8.3 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.8.4 Pfizer Inc. Business Overview
10.8.5 Pfizer Inc. Recent Developments
10.9 Sun Pharmaceutical Industries Ltd
10.9.1 Sun Pharmaceutical Industries Ltd Basic Information
10.9.2 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.9.3 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.9.4 Sun Pharmaceutical Industries Ltd Business Overview
10.9.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.10 Xencor Inc.
10.10.1 Xencor Inc. Basic Information
10.10.2 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
10.10.3 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Market Performance
10.10.4 Xencor Inc. Business Overview
10.10.5 Xencor Inc. Recent Developments
11 GASTROINTESTINAL STROMAL TUMORS THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast
11.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region
11.2.4 South America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gastrointestinal Stromal Tumors Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumors Therapeutics by Type (2026-2033)
12.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumors Therapeutics by Type (2026-2033)
12.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast by Application (2026-2033)
12.2.1 Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Stromal Tumors Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gastrointestinal Stromal Tumors Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumors Therapeutics as of 2024)
Table 10. Global Market Gastrointestinal Stromal Tumors Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Gastrointestinal Stromal Tumors Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gastrointestinal Stromal Tumors Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Type (K Units)
Table 26. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (M USD)
Table 27. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Type (2020-2025)
Table 28. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Type (2020-2025)
Table 29. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) by Type (2020-2025)
Table 30. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Share by Type (2020-2025)
Table 31. Global Gastrointestinal Stromal Tumors Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 32. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Application
Table 33. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Application
Table 34. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Application (2020-2025) & (K Units)
Table 35. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application (2020-2025)
Table 36. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application (2020-2025)
Table 38. Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2020-2025)
Table 39. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2020-2025) & (K Units)
Table 40. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region (2020-2025)
Table 41. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region (2020-2025)
Table 43. North America Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2020-2025) & (K Units)
Table 44. North America Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2020-2025) & (K Units)
Table 50. South America Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Gastrointestinal Stromal Tumors Therapeutics Production (K Units) by Region(2020-2025)
Table 54. Global Gastrointestinal Stromal Tumors Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Region (2020-2025)
Table 56. Global Gastrointestinal Stromal Tumors Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Gastrointestinal Stromal Tumors Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Gastrointestinal Stromal Tumors Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Gastrointestinal Stromal Tumors Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Gastrointestinal Stromal Tumors Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Ascentage Pharma Group International Basic Information
Table 62. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 63. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Ascentage Pharma Group International Business Overview
Table 65. Ascentage Pharma Group International SWOT Analysis
Table 66. Ascentage Pharma Group International Recent Developments
Table 67. Bayer AG Basic Information
Table 68. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 69. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Bayer AG Business Overview
Table 71. Bayer AG SWOT Analysis
Table 72. Bayer AG Recent Developments
Table 73. Blueprint Medicines Corp Basic Information
Table 74. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 75. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Blueprint Medicines Corp Business Overview
Table 77. Blueprint Medicines Corp SWOT Analysis
Table 78. Blueprint Medicines Corp Recent Developments
Table 79. Bristol Myers Squibb Co. Basic Information
Table 80. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 81. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Bristol Myers Squibb Co. Business Overview
Table 83. Bristol Myers Squibb Co. Recent Developments
Table 84. Deciphera Pharmaceuticals Inc Basic Information
Table 85. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 86. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Deciphera Pharmaceuticals Inc Business Overview
Table 88. Deciphera Pharmaceuticals Inc Recent Developments
Table 89. Immunicum AB Basic Information
Table 90. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 91. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Immunicum AB Business Overview
Table 93. Immunicum AB Recent Developments
Table 94. Novartis AG Basic Information
Table 95. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 96. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Recent Developments
Table 99. Pfizer Inc. Basic Information
Table 100. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 101. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Pfizer Inc. Business Overview
Table 103. Pfizer Inc. Recent Developments
Table 104. Sun Pharmaceutical Industries Ltd Basic Information
Table 105. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 106. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Sun Pharmaceutical Industries Ltd Business Overview
Table 108. Sun Pharmaceutical Industries Ltd Recent Developments
Table 109. Xencor Inc. Basic Information
Table 110. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 111. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Xencor Inc. Business Overview
Table 113. Xencor Inc. Recent Developments
Table 114. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Gastrointestinal Stromal Tumors Therapeutics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Stromal Tumors Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gastrointestinal Stromal Tumors Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumors Therapeutics as of 2024)
Table 10. Global Market Gastrointestinal Stromal Tumors Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Gastrointestinal Stromal Tumors Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gastrointestinal Stromal Tumors Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Type (K Units)
Table 26. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (M USD)
Table 27. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Type (2020-2025)
Table 28. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Type (2020-2025)
Table 29. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) by Type (2020-2025)
Table 30. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Share by Type (2020-2025)
Table 31. Global Gastrointestinal Stromal Tumors Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 32. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) by Application
Table 33. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Application
Table 34. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Application (2020-2025) & (K Units)
Table 35. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application (2020-2025)
Table 36. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application (2020-2025)
Table 38. Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2020-2025)
Table 39. Global Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2020-2025) & (K Units)
Table 40. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region (2020-2025)
Table 41. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region (2020-2025)
Table 43. North America Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2020-2025) & (K Units)
Table 44. North America Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Gastrointestinal Stromal Tumors Therapeutics Sales by Country (2020-2025) & (K Units)
Table 50. South America Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Gastrointestinal Stromal Tumors Therapeutics Production (K Units) by Region(2020-2025)
Table 54. Global Gastrointestinal Stromal Tumors Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Region (2020-2025)
Table 56. Global Gastrointestinal Stromal Tumors Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Gastrointestinal Stromal Tumors Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Gastrointestinal Stromal Tumors Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Gastrointestinal Stromal Tumors Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Gastrointestinal Stromal Tumors Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Ascentage Pharma Group International Basic Information
Table 62. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 63. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Ascentage Pharma Group International Business Overview
Table 65. Ascentage Pharma Group International SWOT Analysis
Table 66. Ascentage Pharma Group International Recent Developments
Table 67. Bayer AG Basic Information
Table 68. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 69. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Bayer AG Business Overview
Table 71. Bayer AG SWOT Analysis
Table 72. Bayer AG Recent Developments
Table 73. Blueprint Medicines Corp Basic Information
Table 74. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 75. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Blueprint Medicines Corp Business Overview
Table 77. Blueprint Medicines Corp SWOT Analysis
Table 78. Blueprint Medicines Corp Recent Developments
Table 79. Bristol Myers Squibb Co. Basic Information
Table 80. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 81. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Bristol Myers Squibb Co. Business Overview
Table 83. Bristol Myers Squibb Co. Recent Developments
Table 84. Deciphera Pharmaceuticals Inc Basic Information
Table 85. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 86. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Deciphera Pharmaceuticals Inc Business Overview
Table 88. Deciphera Pharmaceuticals Inc Recent Developments
Table 89. Immunicum AB Basic Information
Table 90. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 91. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Immunicum AB Business Overview
Table 93. Immunicum AB Recent Developments
Table 94. Novartis AG Basic Information
Table 95. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 96. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Recent Developments
Table 99. Pfizer Inc. Basic Information
Table 100. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 101. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Pfizer Inc. Business Overview
Table 103. Pfizer Inc. Recent Developments
Table 104. Sun Pharmaceutical Industries Ltd Basic Information
Table 105. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 106. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Sun Pharmaceutical Industries Ltd Business Overview
Table 108. Sun Pharmaceutical Industries Ltd Recent Developments
Table 109. Xencor Inc. Basic Information
Table 110. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Overview
Table 111. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Xencor Inc. Business Overview
Table 113. Xencor Inc. Recent Developments
Table 114. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Gastrointestinal Stromal Tumors Therapeutics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gastrointestinal Stromal Tumors Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastrointestinal Stromal Tumors Therapeutics Product Life Cycle
Figure 13. Gastrointestinal Stromal Tumors Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Gastrointestinal Stromal Tumors Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gastrointestinal Stromal Tumors Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumors Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Gastrointestinal Stromal Tumors Therapeutics
Figure 19. Global Gastrointestinal Stromal Tumors Therapeutics Market PEST Analysis
Figure 20. Global Gastrointestinal Stromal Tumors Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Type
Figure 27. Sales Market Share of Gastrointestinal Stromal Tumors Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Gastrointestinal Stromal Tumors Therapeutics by Type in 2024
Figure 29. Market Size Share of Gastrointestinal Stromal Tumors Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Gastrointestinal Stromal Tumors Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application
Figure 33. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application in 2024
Figure 37. Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gastrointestinal Stromal Tumors Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gastrointestinal Stromal Tumors Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gastrointestinal Stromal Tumors Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Gastrointestinal Stromal Tumors Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gastrointestinal Stromal Tumors Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gastrointestinal Stromal Tumors Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gastrointestinal Stromal Tumors Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gastrointestinal Stromal Tumors Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Gastrointestinal Stromal Tumors Therapeutics Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Gastrointestinal Stromal Tumors Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastrointestinal Stromal Tumors Therapeutics Product Life Cycle
Figure 13. Gastrointestinal Stromal Tumors Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Gastrointestinal Stromal Tumors Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gastrointestinal Stromal Tumors Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumors Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Gastrointestinal Stromal Tumors Therapeutics
Figure 19. Global Gastrointestinal Stromal Tumors Therapeutics Market PEST Analysis
Figure 20. Global Gastrointestinal Stromal Tumors Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Type
Figure 27. Sales Market Share of Gastrointestinal Stromal Tumors Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Gastrointestinal Stromal Tumors Therapeutics by Type in 2024
Figure 29. Market Size Share of Gastrointestinal Stromal Tumors Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Gastrointestinal Stromal Tumors Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application
Figure 33. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Gastrointestinal Stromal Tumors Therapeutics Market Share by Application in 2024
Figure 37. Global Gastrointestinal Stromal Tumors Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gastrointestinal Stromal Tumors Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gastrointestinal Stromal Tumors Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gastrointestinal Stromal Tumors Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gastrointestinal Stromal Tumors Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gastrointestinal Stromal Tumors Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gastrointestinal Stromal Tumors Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gastrointestinal Stromal Tumors Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Gastrointestinal Stromal Tumors Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gastrointestinal Stromal Tumors Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gastrointestinal Stromal Tumors Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gastrointestinal Stromal Tumors Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gastrointestinal Stromal Tumors Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gastrointestinal Stromal Tumors Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Gastrointestinal Stromal Tumors Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Gastrointestinal Stromal Tumors Therapeutics Market Share Forecast by Application (2026-2033)
